4//SEC Filing
Freund John Gordon 4
Accession 0001062993-25-014202
CIK 0001267565other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:18 PM ET
Size
10.1 KB
Accession
0001062993-25-014202
Insider Transaction Report
Form 4
Freund John Gordon
Director
Transactions
- Sale
Common Stock
2025-08-08$34.36/sh−11,659$400,641→ 23,129 total(indirect: By Partnership)
Holdings
- 70,658
Common Stock
- 8,625(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.27 to $34.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.
- [F3]The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The Reporting Person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001296771
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:18 PM ET
- Size
- 10.1 KB